Modulation of CD59 expression by restrictive silencer factor-derived peptides in cancer immunotherapy for neuroblastoma.

Donev, Rossen M; Gray, Lisa C; Sivasankar, Baalasubramanian; Hughes, Timothy R; van den Berg, Carmen W; Morgan, B Paul

Donev, Rossen M; Gray, Lisa C; Sivasankar, Baalasubramanian; Hughes, Timothy R; van den Berg, Carmen W; Morgan, B Paul.

Affiliation

Donev RM; Department of Medical Biochemistry and Immunology, School of Medicine, Cardiff University, Cardiff, United Kingdom. donevrm@cardiff.ac.uk

Cancer Res ; 68(14): 5979-87, 2008 Jul 15.

Article in En | MEDLINE | ID: mdl-18632654

Subject(s)

Brain Neoplasms/immunology; Brain Neoplasms/therapy; CD59 Antigens/biosynthesis; Gene Expression Regulation, Neoplastic; Immunotherapy/methods; Neuroblastoma/immunology; Neuroblastoma/therapy; Repressor Proteins/metabolism; Cell Line, Tumor; Cell Nucleus/metabolism; Complement System Proteins; Gene Expression Profiling; Gene Silencing; Humans; Peptides/chemistry; RNA Interference

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Repressor Proteins / Brain Neoplasms / Gene Expression Regulation, Neoplastic / CD59 Antigens / Immunotherapy / Neuroblastoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cancer Res Year: 2008 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google